Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04047875Phase 4Completed
A Phase 4 trial of norethindrone in breakthrough bleeding, sponsored by Universidade de São Paulo. Started Sep 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04047875.